Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.5.0.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES    
Net (loss) $ (13,027) $ (14,470)
Adjustments to reconcile net (loss) to net cash (used in) operating activities:    
Depreciation 1,502 971
Amortization 260 26
Provision for bad debts 8 213
Stock-based compensation 1,538 2,178
Change in fair value of business acquisition (119) 91
Change in fair value of warrant liability (729) (18)
Amortization of debt issuance costs 9 5
Loss in equity method investment 45 748
Changes in:    
Accounts receivable (7,066) (349)
Other current assets (67) (368)
Other non-current assets (9) (86)
Accounts payable, accrued expenses and deferred revenue 372 1,330
Deferred rent payable and other (16) (59)
Net cash (used in) operating activities (17,299) (9,950)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of fixed assets (345) (440)
Decrease in restricted cash 0 6,000
Patent costs (127) (109)
Deposit for acquisition of Response Genetics 0 (880)
Net cash provided by (used in) investing activities (472) 4,571
CASH FLOWS FROM FINANCING ACTIVITIES    
Principal payments on capital lease obligations (101) (44)
Payments for deferred equity offering costs 0 (237)
Proceeds from option exercises 0 23
Proceeds from offerings of common stock with derivative warrants, net of certain offering costs 9,962 34
Principal payments on bank term note (833) 0
Payment of debt issuance costs 0 (33)
Net cash provided by (used in) financing activities 9,028 (257)
Net (decrease) in cash and cash equivalents (8,743) (5,636)
CASH AND CASH EQUIVALENTS    
Beginning 19,459 25,554
Ending 10,716 19,918
SUPPLEMENTAL CASH FLOW DISCLOSURE    
Cash paid for interest 250 158
BioServe    
Adjustments to reconcile net (loss) to net cash (used in) operating activities:    
Change in fair value of business acquisition (119) 91
Gentris    
Adjustments to reconcile net (loss) to net cash (used in) operating activities:    
Change in fair value of business acquisition $ 0 $ (162)